Pharmacy Continence Care - Bladder and Bowel Website

More documents

Recommendations

Info

ACKNOWLEDGEMENTS NOVA Public Policy gratefully acknowledges the contributions to this project of: • All the pharmacists and pharmacy staff in the 50 pharmacies around Australia that participated in the project. • Dr Simone Jones, Research and Development Grants Program Manager, The Pharmacy Guild of Australia and Ms Erica Vowles, Acting Research and Development Grants Program Manager, The Pharmacy Guild of Australia, both of whom gave generously of their time at various stages of this project and worked collegially and supportively with all members of the NOVA Public Policy project team • The Pharmacy Group Expert Advisory Group for this project, comprising o Peter McBeath, National Councillor, The Pharmacy Guild of Australia o Dr John Primrose – Senior Medical Advisor, Pharmaceutical Access and Quality Branch, Department of Health and Ageing Public Policy o Kerry Markoulli, Director, Special Needs Strategies Section, Department of Health and Ageing o Matthew Ryan, Pharmaceutical Society of Australia o Hugh Carter, Consumer Representative o Khin Win May, The Pharmacy Guild of Australia (staff) o Fiona Campbell, Assistant Director, Special Needs Strategies Section, Department of Health and Ageing with executive support from Simone Jones and Erica Vowles, The Pharmacy Guild of Australia • Assoc. Professor, Richard Millard, Professor of Urology, University of NSW, The Prince of Wales Hospital, Sydney for pro bono provision of the flip chart design, text and CD ROM developed by him and used as the basis for a set of information materials for general practitioners, Treating Urinary Incontinence in the Community, which in 2004 was distributed to all GPs in Australia through the Department of Health and Ageing National Continence Management Strategy • the NOVA Public Policy panel of expert advisers that provided the NOVA team with clinical, pharmacological and industry advice and guidance on the design, implementation and evaluation of the project and supportive advice on clinical, practice and research issues that arose during the conduct of the project. Panel members were: o John Bell, Pharmacist, Woollahra, NSW o Assoc. Professor Richard Millard, Professor of Urology, University of NSW, The Prince of Wales Hospital, Sydney o Assoc. Professor Kate H Moore, School of Women’s and Children’s Health, University of NSW, St George Hospital, Kogarah, NSW o Rebekah Moles, Assistant Lecturer, Faculty of Pharmacy, University of Sydney o Alice-Anne Macnaught, adviser in carer issues and experience, ACT • those individuals who generously and openly contributed their personal experiences to the development of professional and consumer information materials for the project Final Report i NOVA Public Policy Pharmacy Continence Care Project
• Abena-Sanicare, contracted by NOVA to undertake the training of staff in participating pharmacies; in particular, Andrew Smart, National Training Manager, who worked in collaboration with NOVA in planning the training schedule • the Continence Foundation of Australia, and particularly Barry Cahill, CEO, Anne Haag, Project Officer, and Nevis Zerafa, Health Promotions Manager, for advice on consumer information materials and for publication of the Pharmacy Continence Care Project special edition of the consumer magazine Bridge in Autumn 2005, providing all pharmacies with consumer give-away copies of this edition • Ipsos Australia Pty Ltd, of Melbourne, contracted by NOVA to undertake the consumer survey and data analysis; in particular, Graeme Peacock, Project Manager, and Melissa Viers for her work on and contribution to the consumer questionnaires, follow-up survey and evaluation report. The project was funded by the Australian Government Department of Health and Ageing as part of the Third Community Pharmacy Agreement. Final Report ii NOVA Public Policy Pharmacy Continence Care Project
Page 1: NOVA Public Policy A registered bus
Page 5 and 6: CONTENTS Glossary of Acronyms .....
Page 7 and 8: Figure 11: Pharmacy responses to PI
Page 9 and 10: Glossary of Acronyms CATI computer
Page 11 and 12: Program was based on assessment of
Page 13 and 14: o CQI points through the QCPP for c
Page 15 and 16: materials, the Pharmacist Training
Page 17 and 18: • evaluation of the pilot program
Page 19 and 20: 2 METHODOLOGY The methodology for t
Page 21 and 22: Consumer recruitment was part of th
Page 23 and 24: methodology that assessed the pilot
Page 25 and 26: 3 IMPLEMENTATION OF THE PILOT PROGR
Page 27 and 28: ased on either their customer popul
Page 29 and 30: • self-paced using the CD-ROM/web
Page 31 and 32: focus was on embedding the practice
Page 33 and 34: and faxed newsletter, of an extensi
Page 35 and 36: prior to training (PIQ) and the sam
Page 37 and 38: Level of knowledge and level of con
Page 39 and 40: 45% 40% 35% 30% 25% 20% 15% 10% 5%
Page 41 and 42: 80% 70% 60% 50% 40% 30% 20% 10% 0%
Page 43 and 44: Average of responses 100 90 80 70 6
Page 45 and 46: Average rating on a four point scal
Page 47 and 48: maternal health services and the Co
Page 49 and 50: 4.2.7 Changes in pharmacy behaviour
Page 51 and 52: predetermined training calendar: mo
Page 53 and 54:
measures impact of incontinence on
Page 55 and 56:
In the follow-up survey, there was
Page 57 and 58:
• Did not find incontinence clini
Page 59 and 60:
Her mother’s dementia, coupled wi
Page 61 and 62:
pharmacy staff report increased con
Page 63 and 64:
period with a national recruitment
Page 65 and 66:
o of a data base of training partic
Page 67 and 68:
health education and working in par
Page 69 and 70:
6 RECOMMENDATION AND IMPLEMENTATION
Page 71 and 72:
7 BIBLIOGRAPHY Adair, G., (1984). T
Page 73:
Rosenstock, I. M. (1974). Historica
show all

Pharmacy Continence Care - Bladder and Bowel Website

Create successful ePaper yourself

Delete template?

Save as template?